We are live on ! Find out more
GF

Genworth Financial Portfolio holdings

AUM $486M
1-Year Est. Return 19.32%
This Fund
S&P 500
This Quarter Est. Return
-3.91%
1 Year Est. Return
+19.32%
3 Year Est. Return
+64.01%
5 Year Est. Return
+73.19%
10 Year Est. Return
AUM
$285M
AUM Growth
-$12M
Cap. Flow
-$365K
Cap. Flow %
-0.13%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$309K
2
ACLX
Arcellx
ACLX
+$56.6K

Sector Composition

Rank Sector Weight
1 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
1
iShares Core S&P 500 ETF
IVV
$884B
$258M 90.77%
601,470
SPLV icon
2
Invesco S&P 500 Low Volatility ETF
SPLV
$7.2B
$26.3M 9.23%
446,687
ACLX
3
DELISTED
Arcellx
ACLX
-1,791
Closed -$56.6K
MIRM icon
4
Mirum Pharmaceuticals
MIRM
$6.36B
-11,939
Closed -$309K

Similar funds

Genworth Financial's Q3 2023 Portfolio in Review

As of Q3 2023, Genworth Financial held 4 positions worth $285M, down 4% from $297M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Genworth Financial's Q3 2023 filing shows 2 closed positions. The largest sale was Mirum Pharmaceuticals, an estimated $309K.

By sector, the portfolio is most concentrated in Healthcare at 0% of assets, down from 0.12% a quarter earlier.

  • Genworth Financial fully exited Mirum Pharmaceuticals in Q3 2023, selling an estimated $309K.
  • Genworth Financial's ten largest holdings make up 100% of its $285M portfolio in Q3 2023.
  • Genworth Financial opened 0 new positions and closed 2 in Q3 2023.
  • Genworth Financial's portfolio value fell 4% quarter-over-quarter to $285M.

Based on Genworth Financial's 13F filing for Q3 2023, filed 25 Oct 2023.